PATENTSCOPE will be unavailable a few hours for maintenance reason on Tuesday 19.11.2019 at 4:00 PM CET
Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (EP3413888) BOWEL CARE USING IONTOPHORESIS

Office : European Patent Office
Application Number: 17750983 Application Date: 13.02.2017
Publication Number: 3413888 Publication Date: 19.12.2018
Publication Kind : A2
Designated States: AL, AT, BA, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Prior PCT appl.: Application Number:US2017017717 ; Publication Number: Click to see the data
IPC:
A61K 31/407
A61K 31/4015
A61M 31/00
A61N 1/30
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
407
condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
40
having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
4015
having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
M
DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
31
Devices for introducing or retaining media, e.g. remedies, in cavities of the body
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
N
ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
1
Electrotherapy; Circuits therefor
18
Applying electric currents by contact electrodes
20
continuous direct currents
30
Apparatus for iontophoresis or cataphoresis
CPC:
A61K 31/27
A61K 31/40
A61N 1/0428
A61N 1/30
A61N 1/36007
A61P 1/00
Applicants: US GOV AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Inventors: KORSTEN MARK A
BAUMAN WILLIAM A
Priority Data: 201662294874 12.02.2016 US
2017017717 13.02.2017 US
Title: (DE) DARMPFLEGE MITHILFE VON IONTOPHORESE
(EN) BOWEL CARE USING IONTOPHORESIS
(FR) SOIN DE L'INTESTIN PAR IONTOPHORÈSE
Abstract:
(EN) The present disclosure provides compositions and methods for on-going bowel care for persons with chronic intestinal pseudo-obstruction. The compositions and methods can be administered in a non-clinical setting. The compositions comprise acetylcholinesterase inhibitors for stimulating motility of the bowel in combination with anti-cholinergic agents to counteract the potentially dangerous cardiac side effects of the acetylcholinesterase inhibitor. In some examples, the acetylcholinesterase inhibitor, neostigmine, and the anti-cholinergic agent, glycopyrrolate, are combined in a pharmaceutical composition. Certain examples also provide the frequency and duration of administration of the disclosed drug combinations.
(FR) La présente invention concerne des compositions et des procédés pour le soin continu de l'intestin pour des personnes souffrant d'une pseudo-obstruction intestinale chronique. Les compositions et les procédés peuvent être administrés dans un environnement non clinique. Les compositions comprennent des inhibiteurs d'acétylcholinestérase pour stimuler la motilité de l'intestin en combinaison avec des agents anticholinergiques pour contrecarrer les effets secondaires cardiaques potentiellement dangereux de l'inhibiteur d'acétylcholinestérase. Dans certains exemples, l'inhibiteur d'acétylcholinestérase, la néostigmine et l'agent anticholinergique, le glycopyrrolate, sont combinés dans une composition pharmaceutique. Certains exemples donnent également la fréquence et la durée d'administration des combinaisons de médicaments de l'invention.
Also published as:
CA3014586US20190029989WO/2017/139794